# Quantitative Susceptibility Mapping (QSM) to Guide Iron Chelating Therapy

> **NCT04171635** · — · COMPLETED · sponsor: **Weill Medical College of Cornell University** · enrollment: 55 (actual)

## Conditions studied

- MRI Scans

## Interventions

- **RADIATION:** Quantitative Susceptibility Mapping (QSM) Magnetic Resonance Imaging (MRI)
- **RADIATION:** R2* Magnetic Resonance Imaging (MRI)

## Key facts

- **NCT ID:** NCT04171635
- **Lead sponsor:** Weill Medical College of Cornell University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-12-16
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 55 (ACTUAL)
- **Last updated:** 2026-02-27

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04171635

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04171635, "Quantitative Susceptibility Mapping (QSM) to Guide Iron Chelating Therapy". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT04171635. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*